Skip to Main Content
Title
Medicaid policies for HIV-related prescription drugs.
First Author
Buchanan, Robert J
Date of Pub
1994 Spring
Pages
43-61
Volume
15
Issue
3
Other Authors
Smith, Scott R
Abstract
As State Medicaid programs become increasingly important sources of payment for acquired immunodeficiency syndrome (AIDS)-related care, and drug regimens the major weapons available to fight human immunodeficiency virus (HIV)-related illnesses, Medicaid drug policies will have a substantial impact. State Medicaid programs were surveyed to identify policies on a range of prescription drug policies affecting these recipients. All Medicaid programs provide prescription drug benefits to all categorically needy recipients, and about three-fourths of the States provide these benefits to medically needy recipients. However, utilization limits, copayments, and off-label-use and prior-authorization policies in many States weaken the drug benefit available.
Abstract Continued
N/A
MeSH
Comparative Study : Cost Sharing : Data Collection : Drug Costs : Eligibility Determination : Health Policy/economics : HIV Infections/drug therapy/economics : Human : Insurance, Pharmaceutical Services/economics/statistics & numerical data : Medicaid/economics/statistics & numerical data : Prescriptions, Drug/economics : State Health Plans/economics : Support, U.S. Gov't, P.H.S. : United States
NTIS Number
PB95-123477